IPCA Labs -Sikkim Operation by this year.

In an interview with CNBC-TV18, AK Jain, Executive Director of IPCA Laboratories, spoke about the company’s working and future plans.

A: We have one facility which his commercially ready now, about Rs 100 crore. We have invested in the SEZ at Indore facility and we are awaiting the USFDA inspection of that particular facility. In current financial year we also started construction at a new plant at Sikkim. The facility should be operational by the next financial year. This will give the company a large amount of that tax break and in this financial year both these facilities which are on formulation side and on API side we have built up two more facilities at our Ratlam plant in this financial year.

One facility is more particularly for an MNC client for which we have signed a long term contract for supply of two cardiovascular drugs. So it is for supply of those drugs we have put up a new facility at Ratlam. One facilitiy is only to meet the normal demand of API and our basket has become very strong and we are producing almost around 75 API currently and to augment the capacity we have put up as additional facility.